From: Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study
Patient | Extracorporeal circuit during treatment | |||||||
---|---|---|---|---|---|---|---|---|
Mediator | Before extracorporeal treatment | After 6 h extracorporeal treatment | % | P | Directly before cell compartment | Directly behind cell compartment | % | P |
IL-2 | 3.67 | 11.92 | 325 | n.s. | 0.78 | 1.42 | 182 | < 0.05 |
IL-4 | 0.87 | 2.29 | 263 | n.s. | 0.09 | 0.24 | 268 | <0.001 |
IL-6 | 102.22 | 313.15 | 306 | n.s. | 226.06 | 299.38 | 132 | n.s. |
IL-8 | 20.39 | 41.31 | 203 | <0.05 | 31.79 | 165.15 | 520 | <0.001 |
IL-10 | 2.57 | 6.54 | 254 | <0.01 | 3.86 | 6.02 | 156 | <0.05 |
IL-1 beta | 1.21 | 2.12 | 175 | <0.05 | 0.74 | 1.11 | 150 | <0.05 |
IL-5 | 0.42 | 1.33 | 315 | n.s. | 0.39 | 0.52 | 135 | n.s. |
IL-7 | 3.19 | 5.19 | 163 | n.s. | 2.64 | 4.14 | 157 | n.s. |
IL-12(p70) | 2.46 | 9.65 | 392 | n.s. | 0.09 | 0.45 | 498 | <0.001 |
IL-13 | 1.68 | 3.34 | 199 | n.s. | 0.85 | 1.05 | 124 | n.s. |
IL-17 | 0.05 | 0.59 | 1185 | n.s. | 0.04 | 0.10 | 274 | n.s. |
IL-1ra | 106.96 | 208.03 | 194 | n.s. | 113.40 | 134.53 | 119 | n.s. |
IL-15 | 4.19 | 6.35 | 151 | n.s. | 3.20 | 4.37 | 136 | n.s. |
IL-9 | 1.11 | 8.15 | 737 | n.s. | 0.29 | 0.78 | 265 | n.s. |
IP-10 | 240.16 | 561.57 | 234 | n.s. | 508.51 | 749.08 | 147 | <0.05 |
G-CSF | 30.84 | 43.73 | 142 | n.s. | 50.87 | 53.44 | 105 | n.s. |
GM-CSF | 10.81 | 50.79 | 470 | n.s. | 1.52 | 3.41 | 224 | n.s. |
IFN gamma | 50.29 | 79.07 | 157 | n.s. | 14.83 | 25.26 | 170 | <0.05 |
TNF alpha | 0.00 | 0.00 | 100 | n.s. | 0.81 | 0.19 | 24 | n.s. |
MCP-1(MCAF) | 130.72 | 224.46 | 172 | n.s. | 299.52 | 225.67 | 75 | n.s. |
MIP-1b | 55.93 | 98.89 | 177 | n.s. | 76.92 | 103.23 | 134 | n.s. |
Eotaxin | 85.64 | 216.82 | 253 | <0.05 | 80.23 | 130.72 | 163 | <0.01 |
FGF basic | 1.51 | 9.47 | 629 | n.s. | 0.61 | 0.00 | 0 | n.s. |
PDGF bb | 652.01 | 1145.02 | 176 | n.s. | 10.28 | 62.25 | 606 | <0.001 |
RANTES | 137.70 | 298.64 | 217 | <0.05 | 22.91 | 141.43 | 617 | <0.001 |
VEGF | 168.92 | 198.68 | 118 | n.s. | 1.12 | 2.45 | 219 | n.s. |
MIP-1 alpha | 0.39 | 1.00 | 253 | n.s. | 0.34 | 0.51 | 148 | n.s. |